scispace - formally typeset
P

Ping Liang

Researcher at Brock University

Publications -  110
Citations -  6268

Ping Liang is an academic researcher from Brock University. The author has contributed to research in topics: Genome & Gene. The author has an hindex of 39, co-authored 103 publications receiving 5770 citations. Previous affiliations of Ping Liang include Halifax & University at Buffalo.

Papers
More filters
Journal ArticleDOI

Genome sequence of Halobacterium species NRC-1

TL;DR: Analysis of the genome sequence shows the presence of pathways for uptake and utilization of amino acids, active sodium-proton antiporter and potassium uptake systems, sophisticated photosensory and signal transduction pathways, and DNA replication, transcription, and translation systems resembling more complex eukaryotic organisms.
Journal ArticleDOI

Molecular chaperones and the cytoskeleton

TL;DR: It is concluded that molecular chaperones have different but cooperative roles in the formation and function of the eukaryotic cell cytoskeleton.
Journal ArticleDOI

Fluctuation AnaLysis CalculatOR

TL;DR: The FALCOR rate calculator is a web tool designed for use with Luria-Delbrück fluctuation analysis to calculate the frequency and rate from various mutation assays in bacteria and yeast.
Journal ArticleDOI

Human genomic deletions mediated by recombination between Alu elements.

TL;DR: It is found that Alu recombination-mediated genomic deletion has had a much higher impact than was inferred from previously identified isolated events and that it continues to contribute to the dynamic nature of the human genome.
Journal ArticleDOI

Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology.

TL;DR: The results indicated that decreased Kelch-like ECH-associated protein, Keap1, might be an important mechanism for the increased nuclear translocation and activation of Nrf2 in response to hypoxia/reoxygenation, and suggests that the NRF2-Prx1 axis may be a fruitful target for intervention with respect to inhibiting the malignant progression and/or reducing the treatment resistance of cancer cells.